Bruce M. Cohen - Publications

Affiliations: 
Psychiatry Harvard University, Cambridge, MA, United States 

75 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Chouinard V, Chen X, Gardner ME, Valeri L, Kuan E, Cohen BM, Du F, Ongur D. Effects of Olanzapine on Brain Energy Metabolism Measured by 31P-Magnetic Resonance Spectroscopy in Healthy Individuals Without History of Psychiatric Disorders Biological Psychiatry. 87: S167. DOI: 10.1016/J.Biopsych.2020.02.442  0.308
2019 Cohen BM. Evidence-Based Drug Treatment of Acute Depression in Bipolar Disorder. Jama Psychiatry. PMID 31596477 DOI: 10.1001/Jamapsychiatry.2019.3012  0.306
2019 Ni P, Noh H, Park GH, Shao Z, Guan Y, Park JM, Yu S, Park JS, Coyle JT, Weinberger DR, Straub RE, Cohen BM, McPhie DL, Yin C, Huang W, et al. iPSC-derived homogeneous populations of developing schizophrenia cortical interneurons have compromised mitochondrial function. Molecular Psychiatry. PMID 31019265 DOI: 10.1038/S41380-019-0423-3  0.307
2018 Yuksel C, Yilmaz S, Nesbit A, Carkaxhiu G, Ravichandran C, Salvatore P, Pingali S, Cohen B, Ongur D. Demographic and clinical characteristics associated with a history of bizarre delusions in a cross-diagnostic sample of individuals with psychotic disorders. Asian Journal of Psychiatry. 31: 82-85. PMID 29453145 DOI: 10.1016/J.Ajp.2018.02.011  0.313
2017 Kim SY, Kaufman MJ, Cohen BM, Jensen JE, Coyle JT, Du F, Öngür D. In Vivo Brain Glycine and Glutamate Concentrations in Patients With First-Episode Psychosis Measured by Echo Time-Averaged Proton Magnetic Resonance Spectroscopy at 4T. Biological Psychiatry. PMID 29031411 DOI: 10.1016/J.Biopsych.2017.08.022  0.317
2017 Du F, Yuksel C, Chouinard VA, Huynh P, Ryan K, Cohen BM, Öngür D. Abnormalities in High-Energy Phosphate Metabolism in First-Episode Bipolar Disorder Measured Using (31)P-Magnetic Resonance Spectroscopy. Biological Psychiatry. PMID 28527566 DOI: 10.1016/J.Biopsych.2017.03.025  0.323
2017 Ravichandran C, Shinn AK, Öngür D, Perlis RH, Cohen B. Frequency of non-right-handedness in bipolar disorder and schizophrenia. Psychiatry Research. 253: 267-269. PMID 28411573 DOI: 10.1016/J.Psychres.2017.04.011  0.334
2017 Chouinard VA, Kim SY, Valeri L, Yuksel C, Ryan KP, Chouinard G, Cohen BM, Du F, Öngür D. Brain bioenergetics and redox state measured by (31)P magnetic resonance spectroscopy in unaffected siblings of patients with psychotic disorders. Schizophrenia Research. PMID 28258794 DOI: 10.1016/J.Schres.2017.02.024  0.321
2016 Brady RO, Tandon N, Masters GA, Margolis A, Cohen BM, Keshavan M, Öngür D. Differential brain network activity across mood states in bipolar disorder. Journal of Affective Disorders. 207: 367-376. PMID 27744225 DOI: 10.1016/J.Jad.2016.09.041  0.306
2016 Van't Veer A, Smith KL, Cohen BM, Carlezon WA, Bechtholt AJ. Kappa-opioid receptors differentially regulate low and high levels of ethanol intake in female mice. Brain and Behavior. 6: e00523. PMID 27688945 DOI: 10.1002/Brb3.523  0.72
2016 Brady RO, Masters GA, Mathew IT, Margolis A, Cohen BM, Öngür D, Keshavan M. State dependent cortico-amygdala circuit dysfunction in bipolar disorder. Journal of Affective Disorders. 201: 79-87. PMID 27177299 DOI: 10.1016/J.Jad.2016.04.052  0.31
2015 Yuksel C, Tegin C, O'Connor L, Du F, Ahat E, Cohen BM, Ongur D. Phosphorus magnetic resonance spectroscopy studies in schizophrenia. Journal of Psychiatric Research. 68: 157-66. PMID 26228415 DOI: 10.1016/J.Jpsychires.2015.06.014  0.312
2015 Forester BP, Harper DG, Georgakas J, Ravichandran C, Madurai N, Cohen BM. Antidepressant effects of open label treatment with coenzyme Q10 in geriatric bipolar depression. Journal of Clinical Psychopharmacology. 35: 338-40. PMID 25874916 DOI: 10.1097/Jcp.0000000000000326  0.323
2015 Yuksel C, Du F, Ravichandran C, Goldbach JR, Thida T, Lin P, Dora B, Gelda J, O'Connor L, Sehovic S, Gruber S, Ongur D, Cohen BM. Abnormal high-energy phosphate molecule metabolism during regional brain activation in patients with bipolar disorder. Molecular Psychiatry. PMID 25754079 DOI: 10.1038/Mp.2015.13  0.31
2015 Hall MH, Chen CY, Cohen BM, Spencer KM, Levy DL, Öngür D, Smoller JW. Genomewide association analyses of electrophysiological endophenotypes for schizophrenia and psychotic bipolar disorders: a preliminary report. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 168: 151-61. PMID 25740047 DOI: 10.1002/Ajmg.B.32298  0.307
2015 John CS, Sypek EI, Carlezon WA, Cohen BM, Öngür D, Bechtholt AJ. Blockade of the GLT-1 Transporter in the Central Nucleus of the Amygdala Induces both Anxiety and Depressive-Like Symptoms. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1700-8. PMID 25586634 DOI: 10.1038/Npp.2015.16  0.731
2015 Arat HE, Chouinard VA, Cohen BM, Lewandowski KE, Öngür D. Diffusion tensor imaging in first degree relatives of schizophrenia and bipolar disorder patients. Schizophrenia Research. 161: 329-39. PMID 25542860 DOI: 10.1016/J.Schres.2014.12.008  0.314
2014 Öngür D, Bechtholt AJ, Carlezon WA, Cohen BM. Glial abnormalities in mood disorders. Harvard Review of Psychiatry. 22: 334-7. PMID 25377605 DOI: 10.1097/Hrp.0000000000000060  0.737
2014 Murphy BL, Ravichandran C, Babb SM, Cohen BM. Naltrexone in bipolar disorder with depression: a double-blind, placebo-controlled study. Journal of Clinical Psychopharmacology. 34: 749-51. PMID 25310199 DOI: 10.1097/Jcp.0000000000000222  0.3
2014 Zubenko GS, Hughes HB, Jordan RM, Lyons-Weiler J, Cohen BM. Differential hippocampal gene expression and pathway analysis in an etiology-based mouse model of major depressive disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 165: 457-66. PMID 25059218 DOI: 10.1002/Ajmg.B.32257  0.317
2014 Smith KL, John CS, Sypek EI, Ongür D, Cohen BM, Barry SM, Bechtholt AJ. Exploring the role of central astrocytic glutamate uptake in ethanol reward in mice. Alcoholism, Clinical and Experimental Research. 38: 1307-14. PMID 24655029 DOI: 10.1111/Acer.12361  0.715
2014 Duncan LE, Holmans PA, Lee PH, O'Dushlaine CT, Kirby AW, Smoller JW, Öngür D, Cohen BM. Pathway analyses implicate glial cells in schizophrenia. Plos One. 9: e89441. PMID 24586781 DOI: 10.1371/Journal.Pone.0089441  0.315
2014 Du F, Cooper AJ, Thida T, Sehovic S, Lukas SE, Cohen BM, Zhang X, Ongür D. In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy. Jama Psychiatry. 71: 19-27. PMID 24196348 DOI: 10.1001/Jamapsychiatry.2013.2287  0.315
2014 Zubenko GS, Hughes HB, Hitchens TK, Cohen BM. Alterations of brain anatomy in mouse model of MDD created by replacement of homologous mouse DNA sequence with an illness-associated 6-base human CREB1 promoter sequence. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 165: 1-8. PMID 24006268 DOI: 10.1002/Ajmg.B.32198  0.32
2013 Brennan BP, Jensen JE, Hudson JI, Coit CE, Beaulieu A, Pope HG, Renshaw PF, Cohen BM. A placebo-controlled trial of acetyl-L-carnitine and α-lipoic acid in the treatment of bipolar depression. Journal of Clinical Psychopharmacology. 33: 627-35. PMID 23948785 DOI: 10.1097/Jcp.0B013E31829A83F5  0.326
2013 Lewandowski KE, Cohen BM, Keshavan MS, Sperry SH, Ongür D. Neuropsychological functioning predicts community outcomes in affective and non-affective psychoses: a 6-month follow-up. Schizophrenia Research. 148: 34-7. PMID 23791391 DOI: 10.1016/J.Schres.2013.05.012  0.312
2013 Van't Veer A, Bechtholt AJ, Onvani S, Potter D, Wang Y, Liu-Chen LY, Schütz G, Chartoff EH, Rudolph U, Cohen BM, Carlezon WA. Ablation of kappa-opioid receptors from brain dopamine neurons has anxiolytic-like effects and enhances cocaine-induced plasticity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1585-97. PMID 23446450 DOI: 10.1038/Npp.2013.58  0.728
2013 Du F, Cooper A, Lukas SE, Cohen BM, Ongür D. Creatine kinase and ATP synthase reaction rates in human frontal lobe measured by ³¹P magnetization transfer spectroscopy at 4T. Magnetic Resonance Imaging. 31: 102-8. PMID 22898695 DOI: 10.1016/J.Mri.2012.06.018  0.3
2012 Brady RO, Cooper A, Jensen JE, Tandon N, Cohen B, Renshaw P, Keshavan M, Öngür D. A longitudinal pilot proton MRS investigation of the manic and euthymic states of bipolar disorder. Translational Psychiatry. 2: e160. PMID 22968227 DOI: 10.1038/Tp.2012.84  0.361
2012 Murphy BL, Stoll AL, Harris PQ, Ravichandran C, Babb SM, Carlezon WA, Cohen BM. Omega-3 fatty acid treatment, with or without cytidine, fails to show therapeutic properties in bipolar disorder: a double-blind, randomized add-on clinical trial. Journal of Clinical Psychopharmacology. 32: 699-703. PMID 22926607 DOI: 10.1097/Jcp.0B013E318266854C  0.308
2012 Ranganathan M, Schnakenberg A, Skosnik PD, Cohen BM, Pittman B, Sewell RA, D'Souza DC. Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans. Biological Psychiatry. 72: 871-9. PMID 22817868 DOI: 10.1016/J.Biopsych.2012.06.012  0.308
2012 Munro TA, Berry LM, Van't Veer A, Béguin C, Carroll FI, Zhao Z, Carlezon WA, Cohen BM. Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity. Bmc Pharmacology. 12: 5. PMID 22642416 DOI: 10.1186/1471-2210-12-5  0.302
2012 Forester BP, Zuo CS, Ravichandran C, Harper DG, Du F, Kim S, Cohen BM, Renshaw PF. Coenzyme Q10 effects on creatine kinase activity and mood in geriatric bipolar depression. Journal of Geriatric Psychiatry and Neurology. 25: 43-50. PMID 22467846 DOI: 10.1177/0891988712436688  0.307
2012 Shinn AK, Pfaff D, Young S, Lewandowski KE, Cohen BM, Öngür D. Auditory hallucinations in a cross-diagnostic sample of psychotic disorder patients: a descriptive, cross-sectional study. Comprehensive Psychiatry. 53: 718-26. PMID 22197213 DOI: 10.1016/J.Comppsych.2011.11.003  0.321
2011 Lewandowski KE, Cohen BM, Keshavan MS, Ongür D. Relationship of neurocognitive deficits to diagnosis and symptoms across affective and non-affective psychoses. Schizophrenia Research. 133: 212-7. PMID 21996265 DOI: 10.1016/J.Schres.2011.09.004  0.307
2011 Chai XJ, Whitfield-Gabrieli S, Shinn AK, Gabrieli JD, Nieto Castañón A, McCarthy JM, Cohen BM, Ongür D. Abnormal medial prefrontal cortex resting-state connectivity in bipolar disorder and schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 2009-17. PMID 21654735 DOI: 10.1038/Npp.2011.88  0.327
2011 Öngür D, Haddad S, Prescot AP, Jensen JE, Siburian R, Cohen BM, Renshaw PF, Smoller JW. Relationship between genetic variation in the glutaminase gene GLS1 and brain glutamine/glutamate ratio measured in vivo. Biological Psychiatry. 70: 169-74. PMID 21457947 DOI: 10.1016/J.Biopsych.2011.01.033  0.309
2011 Bracken BK, Jensen JE, Prescot AP, Cohen BM, Renshaw PF, Ongür D. Brain metabolite concentrations across cortical regions in healthy adults. Brain Research. 1369: 89-94. PMID 21081116 DOI: 10.1016/J.Brainres.2010.11.036  0.316
2011 Lewandowski KE, Cohen BM, Ongur D. Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder. Psychological Medicine. 41: 225-41. PMID 20836900 DOI: 10.1017/S0033291710001042  0.326
2010 Cataldo AM, McPhie DL, Lange NT, Punzell S, Elmiligy S, Ye NZ, Froimowitz MP, Hassinger LC, Menesale EB, Sargent LW, Logan DJ, Carpenter AE, Cohen BM. Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. The American Journal of Pathology. 177: 575-85. PMID 20566748 DOI: 10.2353/Ajpath.2010.081068  0.301
2010 Ongür D, Lundy M, Greenhouse I, Shinn AK, Menon V, Cohen BM, Renshaw PF. Default mode network abnormalities in bipolar disorder and schizophrenia. Psychiatry Research. 183: 59-68. PMID 20553873 DOI: 10.1016/J.Pscychresns.2010.04.008  0.333
2010 Bechtholt-Gompf AJ, Walther HV, Adams MA, Carlezon WA, Ongür D, Cohen BM. Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2049-59. PMID 20531459 DOI: 10.1038/Npp.2010.74  0.324
2010 Nemeth CL, Paine TA, Rittiner JE, Béguin C, Carroll FI, Roth BL, Cohen BM, Carlezon WA. Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats. Psychopharmacology. 210: 263-74. PMID 20358363 DOI: 10.1007/S00213-010-1834-7  0.312
2010 Brennan BP, Hudson JI, Jensen JE, McCarthy J, Roberts JL, Prescot AP, Cohen BM, Pope HG, Renshaw PF, Ongür D. Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 834-46. PMID 19956089 DOI: 10.1038/Npp.2009.191  0.315
2010 Ongür D, Prescot AP, Jensen JE, Rouse ED, Cohen BM, Renshaw PF, Olson DP. T2 relaxation time abnormalities in bipolar disorder and schizophrenia. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 63: 1-8. PMID 19918902 DOI: 10.1002/Mrm.22148  0.312
2009 Carlezon WA, Béguin C, Knoll AT, Cohen BM. Kappa-opioid ligands in the study and treatment of mood disorders. Pharmacology & Therapeutics. 123: 334-43. PMID 19497337 DOI: 10.1016/J.Pharmthera.2009.05.008  0.33
2009 Ongür D, Prescot AP, Jensen JE, Cohen BM, Renshaw PF. Creatine abnormalities in schizophrenia and bipolar disorder. Psychiatry Research. 172: 44-8. PMID 19239984 DOI: 10.1016/J.Pscychresns.2008.06.002  0.318
2009 Yoon SJ, Lyoo IK, Haws C, Kim TS, Cohen BM, Renshaw PF. Decreased glutamate/glutamine levels may mediate cytidine's efficacy in treating bipolar depression: a longitudinal proton magnetic resonance spectroscopy study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1810-8. PMID 19194376 DOI: 10.1038/Npp.2009.2  0.309
2009 Ongür D, Lin L, Cohen BM. Clinical characteristics influencing age at onset in psychotic disorders. Comprehensive Psychiatry. 50: 13-9. PMID 19059508 DOI: 10.1016/J.Comppsych.2008.06.002  0.315
2008 Ongür D, Jensen JE, Prescot AP, Stork C, Lundy M, Cohen BM, Renshaw PF. Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biological Psychiatry. 64: 718-26. PMID 18602089 DOI: 10.1016/J.Biopsych.2008.05.014  0.326
2008 Cohen BM, Murphy B. The effects of pentazocine, a kappa agonist, in patients with mania. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 11: 243-7. PMID 17897484 DOI: 10.1017/S1461145707008073  0.307
2006 Carlezon WA, Béguin C, DiNieri JA, Baumann MH, Richards MR, Todtenkopf MS, Rothman RB, Ma Z, Lee DY, Cohen BM. Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. The Journal of Pharmacology and Experimental Therapeutics. 316: 440-7. PMID 16223871 DOI: 10.1124/Jpet.105.092304  0.308
2005 Frazier JA, Chiu S, Breeze JL, Makris N, Lange N, Kennedy DN, Herbert MR, Bent EK, Koneru VK, Dieterich ME, Hodge SM, Rauch SL, Grant PE, Cohen BM, Seidman LJ, et al. Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder. The American Journal of Psychiatry. 162: 1256-65. PMID 15994707 DOI: 10.1176/Appi.Ajp.162.7.1256  0.318
2004 Rohan M, Parow A, Stoll AL, Demopulos C, Friedman S, Dager S, Hennen J, Cohen BM, Renshaw PF. Low-field magnetic stimulation in bipolar depression using an MRI-based stimulator. The American Journal of Psychiatry. 161: 93-8. PMID 14702256 DOI: 10.1176/Appi.Ajp.161.1.93  0.316
2003 Kaufman MJ, Henry ME, Frederick Bd, Hennen J, Villafuerte RA, Stoddard EP, Schmidt ME, Cohen BM, Renshaw PF. Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: a proton magnetic resonance spectroscopic imaging study. Biological Psychiatry. 54: 534-9. PMID 12946882 DOI: 10.1016/S0006-3223(02)01828-0  0.307
2003 Lyoo IK, Kong SW, Sung SM, Hirashima F, Parow A, Hennen J, Cohen BM, Renshaw PF. Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate. Psychiatry Research. 123: 87-100. PMID 12850248 DOI: 10.1016/S0925-4927(03)00046-5  0.325
2003 Henry ME, Kaufman MJ, Hennen J, Michelson D, Schmidt ME, Stoddard E, Vukovic AJ, Barreira PJ, Cohen BM, Renshaw PF. Cerebral blood volume and clinical changes on the third day of placebo substitution for SSRI treatment. Biological Psychiatry. 53: 100-5. PMID 12513950 DOI: 10.1016/S0006-3223(02)01441-5  0.302
2002 Loeber RT, Gruber SA, Cohen BM, Renshaw PF, Sherwood AR, Yurgelun-Todd DA. Cerebellar blood volume in bipolar patients correlates with medication. Biological Psychiatry. 51: 370-6. PMID 11904131 DOI: 10.1016/S0006-3223(01)01281-1  0.316
2001 Renshaw PF, Parow AM, Hirashima F, Ke Y, Moore CM, Frederick Bde B, Fava M, Hennen J, Cohen BM. Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression. The American Journal of Psychiatry. 158: 2048-55. PMID 11729024 DOI: 10.1176/Appi.Ajp.158.12.2048  0.304
2000 Moore CM, Breeze JL, Gruber SA, Babb SM, Frederick BB, Villafuerte RA, Stoll AL, Hennen J, Yurgelun-Todd DA, Cohen BM, Renshaw PF. Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disorders. 2: 207-16. PMID 11249799 DOI: 10.1034/J.1399-5618.2000.20302.X  0.329
2000 Stoll AL, Renshaw PF, Yurgelun-Todd DA, Cohen BM. Neuroimaging in bipolar disorder: what have we learned? Biological Psychiatry. 48: 505-17. PMID 11018223 DOI: 10.1016/S0006-3223(00)00982-3  0.34
2000 Henry ME, Moore CM, Kaufman MJ, Michelson D, Schmidt ME, Stoddard E, Vuckevic AJ, Berreira PJ, Cohen BM, Renshaw PF. Brain kinetics of paroxetine and fluoxetine on the third day of placebo substitution: a fluorine MRS study. The American Journal of Psychiatry. 157: 1506-8. PMID 10964871 DOI: 10.1176/Appi.Ajp.157.9.1506  0.3
1999 Kaufman MJ, Pollack MH, Villafuerte RA, Kukes TJ, Rose SL, Mendelson JH, Cohen BM, Renshaw PF. Cerebral phosphorus metabolite abnormalities in opiate-dependent polydrug abusers in methadone maintenance. Psychiatry Research. 90: 143-52. PMID 10466733 DOI: 10.1016/S0925-4927(99)00017-7  0.307
1999 Loeber RT, Sherwood AR, Renshaw PF, Cohen BM, Yurgelun-Todd DA. Differences in cerebellar blood volume in schizophrenia and bipolar disorder. Schizophrenia Research. 37: 81-9. PMID 10227110 DOI: 10.1016/S0920-9964(98)00137-6  0.329
1996 Stoll AL, Sachs GS, Cohen BM, Lafer B, Christensen JD, Renshaw PF. Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patients. Biological Psychiatry. 40: 382-8. PMID 8874839 DOI: 10.1016/0006-3223(95)00423-8  0.328
1996 Christensen JD, Kaufman MJ, Levin JM, Mendelson JH, Holman BL, Cohen BM, Renshaw PF. Abnormal cerebral metabolism in polydrug abusers during early withdrawal: a 31P MR spectroscopy study. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 35: 658-63. PMID 8722816 DOI: 10.1002/Mrm.1910350506  0.322
1995 Wan W, Ennulat DJ, Cohen BM. Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain. Brain Research. 688: 95-104. PMID 8542328 DOI: 10.1016/0006-8993(95)00544-Z  0.304
1995 Stoll AL, Renshaw PF, De Micheli E, Wurtman R, Pillay SS, Cohen BM. Choline ingestion increases the resonance of choline-containing compounds in human brain: an in vivo proton magnetic resonance study. Biological Psychiatry. 37: 170-4. PMID 7727625 DOI: 10.1016/0006-3223(94)00120-R  0.315
1994 Renshaw PF, Yurgelun-Todd DA, Cohen BM. Greater hemodynamic response to photic stimulation in schizophrenic patients: an echo planar MRI study. The American Journal of Psychiatry. 151: 1493-5. PMID 8092341 DOI: 10.1176/Ajp.151.10.1493  0.33
1992 Stoll AL, Renshaw PF, Sachs GS, Guimaraes AR, Miller C, Cohen BM, Lafer B, Gonzalez RG. The human brain resonance of choline-containing compounds is similar in patients receiving lithium treatment and controls: an in vivo proton magnetic resonance spectroscopy study. Biological Psychiatry. 32: 944-9. PMID 1467379 DOI: 10.1016/0006-3223(92)90184-2  0.3
1991 Stoll AL, Cohen BM, Hanin I. Erythrocyte choline concentrations in psychiatric disorders. Biological Psychiatry. 29: 309-21. PMID 2036475 DOI: 10.1016/0006-3223(91)90216-9  0.303
1991 Stoll AL, Cohen BM, Snyder MB, Hanin I. Erythrocyte choline concentration in bipolar disorder: a predictor of clinical course and medication response. Biological Psychiatry. 29: 1171-80. PMID 1888799 DOI: 10.1016/0006-3223(91)90325-G  0.319
1991 Austin LS, Lydiard RB, Ballenger JC, Cohen BM, Laraia MT, Zealberg JJ, Fossey MD, Ellinwood EH. Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorder. Biological Psychiatry. 30: 225-32. PMID 1832972 DOI: 10.1016/0006-3223(91)90107-W  0.312
1987 Zubenko GS, Cohen BM, Lipinski JF. Antidepressant-related akathisia. Journal of Clinical Psychopharmacology. 7: 254-7. PMID 3624508 DOI: 10.1097/00004714-198708000-00009  0.31
1980 Pope HG, Lipinski JF, Cohen BM, Axelrod DT. "Schizoaffective disorder": an invalid diagnosis? A comparison of schizoaffective disorder, schizophrenia, and affective disorder. The American Journal of Psychiatry. 137: 921-7. PMID 6106396 DOI: 10.1176/Ajp.137.8.921  0.329
Show low-probability matches.